{"filings":[{"id":1056483,"accession_number":"0001493152-26-028687","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2026-06-15T20:05:40+00:00","items":["1.02","9.01"],"status":"ready","headline":"Polomar Health Services terminates merger with Altanine, ends patent license","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Merger agreement terminated as of June 12, 2026; deal no longer in best interests of shareholders.","Pinata IP License also terminated; Polomar may sell inhalable sildenafil inventory through Sept 7, 2026.","Polomar to pay Altanine $36,000 in three monthly installments of $12,000 starting June 15, 2026.","Mutual release of merger-related claims; confidentiality and other surviving provisions remain in effect."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":472958,"accession_number":"0001493152-26-023937","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2026-05-15T21:14:45+00:00","items":["8.01","9.01"],"status":"ready","headline":"Polomar Health waives five merger conditions with Altanine; CEO Tierney to step down upon closing","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Polomar and Altanine waive conditions including S-4 effectiveness, Nasdaq listing, $25M equity line, reverse split to $10, and concurrent financing.","CEO Terrence Tierney will resign as CEO upon merger close and become EVP/COO; base salary reduced to $19K/month retroactively.","Tierney receives 500K additional nonqualified stock options; severance modified to 4 months salary plus pro-rata bonus.","Polomar consents to Altanine granting a security interest in Pinata Holdings' assets (all patents) to CWR 1 LLC.","Salary may increase to $24K/month upon $5M equity raise or up-listing to NASDAQ/NYSE; accrued $72,961.51 to be repaid in installments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91831,"accession_number":"0001493152-26-019659","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2026-04-29T23:59:59+00:00","items":["1.02","9.01"],"status":"ready","headline":"ForHumanity terminates exclusive marketing deal with Polomar; Polomar disputes claims","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["ForHumanity Agreement allowed exclusive marketing of certain pharmaceutical products; guaranteed $750K payment, $500K paid.","ForHumanity claims Company's representations were false and fraudulent, inducing the contract.","Polomar believes claims meritless, that ForHumanity lacks standing and is in default under the agreement.","Company evaluating notice; dispute may affect future exclusivity and revenue milestones."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118502,"accession_number":"0001493152-25-027517","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2025-12-12T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Polomar amends ForHumanity deal; sets revenue milestones for exclusivity through 2028","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Second Amendment effective Dec 5, 2025; initial exclusivity extended to June 30, 2025.","Exclusivity extended through Dec 31, 2026 if $1.75M revenue by June 30, 2026.","Exclusivity through June 30, 2027 if $5M revenue by Dec 31, 2026; further targets through 2028.","Guaranteed payments: $100k due Dec 8, $200k due Dec 29, 2025, $200k due Jan 12, 2026; $350k received.","Termination right if average monthly revenue <$100k from Jan 2025 through July 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118501,"accession_number":"0001493152-25-018022","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2025-10-14T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Polomar Health amends Altanine merger exchange ratio: 1:1 common, 5:1 preferred","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Amendment dated Oct 8, 2025 adjusts Exchange Ratio: 1 share Parent Common per Company Common share.","Also 5 shares Parent Preferred per Company Preferred share; effective for the merger closing.","Original merger agreement dated July 23, 2025 among Polomar, its merger sub, and Altanine unchanged otherwise."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134950,"accession_number":"0001641172-25-025989","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2025-08-29T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Polomar Health partners with ForHumanity; $750K guaranteed for exclusive marketing of inhalable drugs","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Guaranteed payments of $750K; $200K already received, with remaining $500K due by Oct 31, 2025.","Exclusivity for inhalable sildenafil and eletriptan through March 31, 2026, extendable via revenue milestones (e.g., $1.5M by Mar 31, 2026; $3M by Jun 30, 2026; $8M for FY 2026).","Initial term 42 months (Mar 17, 2025 – Sep 16, 2028) with automatic renewals if average annual revenues meet $3M (first renewal) and $6M (second renewal).","Fulfillment by Polomar Specialty Pharmacy; IG4 handles account management; additional $50K advance due by Sep 15, 2025.","Product pricing capped at 3% annual increase during initial term; Polomar must reserve 8,000 kits of each product for ForHumanity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134949,"accession_number":"0001641172-25-021413","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2025-07-29T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Polomar Health Services merges with Altanine; Altanine shareholders to own 80% of combined company","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Merger Sub to merge into Altanine; Altanine survives as wholly owned subsidiary.","Altanine common/preferred stock exchanged for Parent common/preferred on a 1:1 basis.","Post-merger: Altanine shareholders own ~80% of Parent common; current Parent holders ~20%.","New board: four Altanine appointees (Hornig, Caruolo, Peterson, Toledano) and one Parent appointee (Del Virginia).","CEO Charles Andres Jr. appointed; Terrence Tierney resigns as interim CEO, becomes EVP & CAO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134948,"accession_number":"0001641172-25-021024","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2025-07-25T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Polomar Health enters $150K promissory note with affiliate CWR; initial $60K draw contingent on merger","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Up to $150,000 borrowing capacity with CWR 1, LLC; initial $60,000 drawn upon signing.","Interest at 12% APR, rising to prime+7% after October 31, 2025 maturity.","Initial draw conditioned on execution of merger agreement between Polomar and Altanine, Inc.","CWR owns ~18% of Polomar; Daniel Gordon (CWR manager) controls ~42% of voting stock.","Certain non-public terms redacted; company intends to amend filing upon public release."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134947,"accession_number":"0001641172-25-020878","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2025-07-24T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Polomar Health enters Registration Rights Agreements with two investors for Series A Convertible Preferred","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Entered Registration Rights Agreements with Reprise Management and CWR 1, LLC on July 18, 2025, effective June 30, 2025.","Company must file registration statement within 30 days of issuance of common shares upon conversion of Preferred Stock.","Investors have piggy-back registration rights on any other registration statement filed by Company.","Company is solely responsible for all expenses associated with registration statement filings.","Agreements stem from previously disclosed Securities Purchase Agreements for Series A Convertible Preferred Stock."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134946,"accession_number":"0001641172-25-018461","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2025-07-09T23:59:59+00:00","items":["1.01","2.03","3.02","5.03","9.01"],"status":"ready","headline":"Polomar Health restructures $897K debt, issues convertible preferred to affiliates, extends maturity to 2027","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reprise note principal reduced to $597,549 using $300K preferred stock proceeds; maturity extended from July 2025 to July 2027; interest reduced to 12%.","CWR note of $450,000 paid in full with proceeds from $450K preferred stock sale to CWR, a related party.","Issued 150 shares of Series A Convertible Preferred Stock at $5,000/share for total $750,000 to two affiliates (Reprise and CWR).","Preferred stock carries 10% cumulative dividend, convertible at $0.40/share, with redemption options and extensive consent rights.","Proceeds used to pay down debt; all transactions involve affiliates of Daniel Gordon, president of Reprise and manager of CWR."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151899,"accession_number":"0001641172-25-004964","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2025-04-16T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Polomar Health posts $1.3M net loss on $58.8K revenue; CFO resigns, 10-K delayed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Terrence Tierney resigned as Treasurer and interim CFO; Charlie Lin appointed CFO and Treasurer at $130K salary.","Revenue for FY 2024 was $58,824 (nil in 2023); net loss widened to $1,305,962 from $416,500.","Operating expenses rose to $1,295,027 from $269,830, mainly legal/accounting fees of $189,675 and payroll $380,476.","Company unable to timely file 10-K for FY 2024; expects to file by April 30, 2025; reverse merger with Polomar completed Sept 30, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170758,"accession_number":"0001493152-25-010634","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2025-03-17T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Polomar Health signs exclusive distribution deal for inhalable sildenafil and sumatriptan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Agreement with ForHumanity Health and Island 40 Group grants exclusivity through Sep 30, 2025, in exchange for $750,000 guaranteed revenue.","ForHumanity made a $250,000 advance payment to secure exclusivity; remaining $500,000 due by June 30, 2025.","Initial term of 3 years through March 2028; auto-renewal for up to 5-year terms if revenue targets met (minimum $3M average annually for first renewal).","Exclusivity can be extended through Dec 31, 2028, if ForHumanity achieves escalating revenue milestones (e.g., $20M by 2027).","Polomar Specialty Pharmacy will fulfill prescriptions; IG4 handles account management."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170757,"accession_number":"0001493152-25-009233","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2025-03-05T23:59:59+00:00","items":["4.02","9.01"],"status":"ready","headline":"Polomar Health restates Q3 2024 financials; acquisition reclassified as recapitalization","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["SEC comment letter prompted reclassification of Sep 30, 2024 acquisition from reverse merger to recapitalization.","Restatement will materially impact previously reported balance sheets and statements of stockholders' deficit.","Net loss, stockholders' equity, EPS, cash flow, and non-GAAP measures are unaffected by the reclassification.","Company plans to file an amended Form 10-Q for the three and nine months ended Sep 30, 2024 as soon as practicable."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170756,"accession_number":"0001493152-25-002154","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2025-01-14T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Polomar Health amends license with Pinata; adds pharmacy sub, sets royalties of 10-20%","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amended license covers metformin (10% royalty), semaglutide/liraglutide (20%), sumatriptan/sildenafil (15%).","License is worldwide, non-exclusive, perpetual; may be terminated with 180 days notice or for uncured breach.","Polomar Specialty Pharmacy, a wholly-owned Florida subsidiary, added as a licensee.","Pinata is an affiliate of CWR 1 LLC, Polomar's majority shareholder (common ownership)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187722,"accession_number":"0001493152-24-044780","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K/A","filed_at":"2024-11-12T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Polomar Health Services assumes $633K promissory note at 12-15% interest in acquisition","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Upon acquiring Polomar Specialty Pharmacy, assumed $633,430 outstanding on unsecured promissory note to Reprise Management.","Note bears 12% simple interest through Dec 31, 2024, then 15% thereafter; matures July 31, 2025.","Total liabilities of Polomar Specialty Pharmacy were ~$576,000 as of June 30, 2024, including $454,000 related-party debt.","On Nov 8, 2024, note was amended to remove a warrant issuance requirement originally tied to the loan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187721,"accession_number":"0001493152-24-042528","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K/A","filed_at":"2024-10-25T23:59:59+00:00","items":["9.01","2.01"],"status":"ready","headline":"Polomar Health Services completes acquisition of Polomar Specialty Pharmacy, files amended 8-K with financials","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Polomar Health Services acquired 100% of Polomar Specialty Pharmacy on September 30, 2024 in exchange for common stock.","Audited financials show $41,844 revenue and $171,497 net loss from inception (April 26, 2023) to December 31, 2023.","Unaudited interim statements for six months ended June 30, 2024 show accumulated deficit of $433,567 and going concern uncertainty.","Short-term debt due to related parties surged from $30,507 (Dec 2023) to $454,288 (June 2024).","Financial statements include a material weakness in liquidity; cash was only $8,564 as of Dec 2023 and $19,563 as of June 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187723,"accession_number":"0001493152-24-041422","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2024-10-17T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Polomar Health Services Amends Articles to Change Name, Increase Preferred Shares, and Reverse Split Stock 1-for-10","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company changed its name from Trustfeed Corp. to Polomar Health Services, Inc. effective October 10, 2024.","Authorized shares of blank check preferred stock increased to 5,000,000.","Effected a 1-for-10 reverse stock split of common shares.","Filed Amended and Restated Articles of Incorporation with Nevada Secretary of State on October 10, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187724,"accession_number":"0001493152-24-039582","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2024-10-04T23:59:59+00:00","items":["1.01","2.01","3.02","5.01","5.02","9.01"],"status":"ready","headline":"Trustfeed Corp. completes reverse merger acquisition of Polomar Specialty Pharmacy","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired 100% of Polomar Specialty Pharmacy in exchange for ~207.4M shares of common stock.","Majority owner CWR 1 canceled 50M shares pre-closing; former Polomar members own ~75% of combined company.","Trustfeed will now operate as a Florida-licensed compounding pharmacy, including SlimRx weight-loss platform.","Entered into IP license with Pinata Holdings for proprietary drug delivery of metformin, semaglutide, etc.","Financial statements to be filed as amendment within 71 days of filing date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204225,"accession_number":"0001493152-24-037582","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2024-09-20T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Trustfeed Corp. issues 10M shares upon conversion of 500K preferred shares to CRW 1, LLC","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["On Sept 12, 2024, Trustfeed issued 10M common shares to CRW 1, LLC upon full conversion of 500K Series A Convertible Preferred shares.","The conversion was executed under Section 4(a)(2) exemption from registration without any public offering.","No other financial details or business updates were included in the filing.","The issuance could be materially dilutive given the company's microcap status."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204224,"accession_number":"0001493152-24-033448","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2024-08-21T23:59:59+00:00","items":["2.03","1.01","9.01"],"status":"ready","headline":"Trustfeed Corp. enters $250K promissory note with affiliate CWR 1 LLC","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Initial draw $157,622.56 used to repay prior undocumented loans from same lender.","Interest rate: prime + 5% (currently 13.5% simple); due July 31, 2025.","Lender CWR 1 LLC is an affiliate of Daniel Gordon and holds majority voting stock.","Loan commitment up to $250K, with prepayment allowed without penalty."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204223,"accession_number":"0001493152-24-028772","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2024-07-23T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Trustfeed Corp. appoints Gabriel Del Virginia as director effective July 18, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Gabriel Del Virginia, 66, appointed to fill board vacancy; term until next annual meeting.","He has over 30 years legal experience at Milbank Tweed Hadley & McCloy and as principal of own firm.","No related party transactions between the company and Del Virginia requiring disclosure."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204222,"accession_number":"0001493152-24-028127","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2024-07-17T23:59:59+00:00","items":[],"status":"ready","headline":"Trustfeed Corp. shareholders approve name change, reverse split, and equity plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Written consent from stockholder holding ~82.87% of common and all Series A preferred (84.3% voting power) approved all proposals.","Name change to Polomar Health Services, Inc. and increase of authorized preferred shares to 5,000,000.","Authorization of 1-for-10 reverse stock split (board may effect at its discretion).","Adoption of 2024 Equity and Incentive Compensation Plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204221,"accession_number":"0001493152-24-026348","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2024-07-05T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Trustfeed Corp. licenses patent-pending IP from affiliate Pinata Holdings for drug delivery products","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Royalty rates: 10% for metformin, 15% for sumatriptan/sildenafil, 20% for semaglutide/liraglutide on net sales.","License is worldwide, non-exclusive, perpetual; termination for material breach or 180 days notice.","Intended use is in products after planned acquisition of Polomar Specialty Pharmacy, announced June 28, 2024.","Pinata Holdings is an affiliate of CWR 1, LLC, the company's majority shareholder (related party transaction).","License covers patent-pending IP and know-how for delivery of five active ingredients (metformin, sumatriptan, semaglutide, liraglutide, sildenafil)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204220,"accession_number":"0001493152-24-026007","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2024-07-02T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Trustfeed Corp. to acquire Polomar Specialty Pharmacy via merger; Polomar members to own 75% of combined company","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Each 1% of Polomar membership converts to 357,414 shares of Trustfeed common stock; no fractional shares.","Post-merger, Polomar members own 75% of Trustfeed; current stockholders own 25%.","CWR 1, LLC (83.3% owner) will convert preferred stock and cancel common shares to ensure at least 10% public float.","Closing conditions include PCAOB-compliant audit of Polomar for FY2023 and shareholder approval of 10:1 reverse split and name change to \"Polomar Health Services, Inc.\"","Trustfeed's board and executive officers remain unchanged after the merger."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":240547,"accession_number":"0001493152-24-011089","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2024-03-25T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Trustfeed Corp. sole officer/director Brett Rosen resigns; Terrence Tierney appointed as interim CEO, CFO, director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brett Rosen resigned from all positions (President, CFO, Secretary, Treasurer, sole director) on March 21, 2024; no disagreements.","Terrence M. Tierney appointed as director and Interim President, CFO, Secretary, Treasurer effective same date.","Tierney compensated $5,000/month for up to 25 hours/month via Professional Services Agreement with Profesco, Inc.","Initial term ends earlier of 5 months or filing of Form 10-Q for period ending June 30, 2024; extendable by mutual consent.","Tierney has over 30 years of senior management experience; currently President of Profesco consulting firm."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":240546,"accession_number":"0001493152-24-006959","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2024-02-16T23:59:59+00:00","items":[],"status":"ready","headline":"Trustfeed Corp. director Rasmus Refer resigns effective February 12, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Rasmus Refer resigned as director effective February 12, 2024.","Resignation previously disclosed on December 29, 2023, subject to Rule 14f-1.","Mr. Refer had no disagreements with the Company regarding operations, policies, or practices."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":240545,"accession_number":"0001493152-24-001095","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2024-01-04T23:59:59+00:00","items":[],"status":"ready","headline":"Trustfeed Corp. changes control: Fastbase sells ~83% stake to CWR 1 LLC for $350k; new CEO appointed.","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Fastbase sold 90,437,591 common shares (~83% of outstanding) and 100% of Series A Preferred to CWR 1 LLC for $350,000.","Rasmus Refer resigned as CEO and director; Brett Rosen appointed President, CFO, Secretary, Treasurer, and director.","New control group is affiliate of GLD Partners, LP; no compensation for Rosen initially.","Share purchase intended to effect change of control in anticipation of a future transaction."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":258053,"accession_number":"0001663577-23-000497","cik":1265521,"company_name":"Polomar Health Services, Inc.","ticker":"PMHS","form_type":"8-K","filed_at":"2023-10-13T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Trustfeed Corp. dismisses Gries & Associates, engages GreenGrowth CPAs as new auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Gries sold its business to GreenGrowth CPAs; Trustfeed dismissed Gries effective Oct 9, 2023.","Engaged GreenGrowth as new independent accountant on Oct 13, 2023 (board approved).","No disagreements with Gries on accounting principles; only material weaknesses in internal control discussed.","Prior Gries reports included going concern qualification but no adverse or modified opinions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":4207964.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}